paeonol has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, QH; Li, Q; Ma, SP; Qu, R; Zhong, SZ | 1 |
| Hsu, YY; Lo, YC; Shih, YT; Tseng, YT | 1 |
2 other study(ies) available for paeonol and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice.
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Avoidance Learning; Cerebral Cortex; Cognition Disorders; Drugs, Chinese Herbal; Galactose; Glutathione; Hippocampus; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred ICR; Neurodegenerative Diseases; Paeonia; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase | 2009 |
Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons.
Topics: Acetophenones; Animals; Animals, Newborn; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclooxygenase 2; Female; Heme Oxygenase-1; Inflammation; Inflammation Mediators; Lipopolysaccharides; Microglia; Mitogen-Activated Protein Kinases; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress; Oxidopamine; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase | 2012 |